Ortho Evra Interactions
There are 465 drugs known to interact with Ortho Evra (ethinyl estradiol/norelgestromin), along with 18 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 62 are major, 357 are moderate, and 46 are minor.
- View all 465 medications that may interact with Ortho Evra
- View Ortho Evra alcohol/food interactions (4)
- View Ortho Evra disease interactions (18)
Most frequently checked interactions
View interaction reports for Ortho Evra (ethinyl estradiol / norelgestromin) and the medicines listed below.
- Abilify (aripiprazole)
- albuterol
- amitriptyline
- amoxicillin
- Ativan (lorazepam)
- bupropion
- citalopram
- clonazepam
- cyclobenzaprine
- Cymbalta (duloxetine)
- diphenhydramine
- Effexor XR (venlafaxine)
- fluoxetine
- gabapentin
- hydroxyzine
- ibuprofen
- levothyroxine
- Lexapro (escitalopram)
- lorazepam
- omeprazole
- Phenergan (promethazine)
- prednisone
- Seroquel (quetiapine)
- sertraline
- Singulair (montelukast)
- Topamax (topiramate)
- trazodone
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
- Zoloft (sertraline)
Ortho Evra alcohol/food interactions
There are 4 alcohol/food interactions with Ortho Evra (ethinyl estradiol / norelgestromin).
Ortho Evra disease interactions
There are 18 disease interactions with Ortho Evra (ethinyl estradiol / norelgestromin) which include:
- smoking
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
More about Ortho Evra (ethinyl estradiol / norelgestromin)
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.